NCT00619905View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ACZ885

DRUG

ACZ885

Trial Locations (10)

Unknown

Novartis Investigator Site, Berlin

Novartis Investigator Site, Cologne

Novartis Investigator Site, Hamburg

Novartis Investigator Site, Leipzig

Novartis Investigator Site, Munich

Novartis Investigator Site, Ratingen

Novartis Investigator Site, Leiden

Novartis Investigator Site, Nijmegen

Novartis Investigator Site, Bern

Novartis Investigator Site, Geneva

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00619905 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate | Biotech Hunter | Biotech Hunter